Dr. Charles Rudin treats lung cancers at MSK, including small cell lung cancer (SCLC), using advanced trials and targeted therapies unique to every patient.
Hi, I'm Dr. Charles Rudin, Deputy Director of Memorial Sloan Kettering Cancer Center and Co-Director of the Druckenmiller Center for Lung Cancer Research. I’ve dedicated my career to advancing lung cancer treatment through groundbreaking research and direct patient care.
My colleagues here at MSK will use our cutting-edge technology to analyze your tumor. Once we understand the specific features of your cancer, we create a treatment plan designed to match the biology of your tumor and your personal needs.
My team focuses on both targeted therapies and immunotherapy, especially for complex cases like small cell lung cancer. We aim to bring you the most effective treatment options available to improve your chances and help you feel more like yourself again.
In the lab, we're constantly working to turn promising scientific discoveries into real treatments. As the leader of several clinical trials, I help to ensure our patients have access to the most advanced therapies, and that these therapeutic approaches are tested and refined with care.
What sets our care apart at MSK is how we combine the latest research with truly personalized medicine. You’ll be surrounded by a team of doctors, researchers, and nurses who are all deeply committed to your care. Together, we’re not only improving outcomes. We’re shaping the future of lung cancer care.